Benzoxaboroles Are Inhibitors of the η ‐Class Carbonic Anhydrase From Plasmodium falciparum
Year: 2026
Type: article
Abstract: ABSTRACT Malaria remains a major global health burden, compounded by increasing resistance to current therapies. Plasmodium falciparum carbonic anhydrase ( Pfa CA), a η ‐class metalloenzyme essential for the parasite metabolism and survival, has recently emerged as a promising antimalarial target. In this study, benzoxaborole 4 and its 6‐substituted triazolyl derivatives ( 5–18 ) were evaluated for Pfa CA inhibition and in vitro antiplasmodial activity against the P. falciparum 3D7 strain. Compounds 13 and 14 emerged as the most potent inhibitors ( K I = 0.45 and 0.43 µM, respectively) of the enzyme, coupled with notable antiplasmodial activity (IC 50 = 34 and 47 µM). Among the tested compounds, the ethyl ester 7 demonstrated the strongest antiplasmodial activity (IC 50 = 2.5 µM). Molecular docking studies further supported the favorable binding of active derivatives within the Pfa CA active site. These findings highlight the potential of benzoxaborole‐based scaffolds as a new chemotype for antimalarial drug development.
Source: Archiv der Pharmazie
DOI: 10.1002/ardp.70201
Institutions: University of Florence, Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Laboratory of Pathogens and Host Immunity, École Nationale Supérieure de Chimie de Montpellier, Institut des Biomolécules Max Mousseron, Institute of Biosciences and Bioresources, National Research Council
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,300
OpenAlex ID: W7128369856
